Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...

Add Yahoo as a preferred source to see more of our stories on Google. On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval of a ...

"My 12-year-old dog Oliver has been diagnosed with lymphoma. Naturally, the vet has referred me to an oncology vet. I do not want to put the dog through chemo, and I asked the vet if he would treat ...

The first full approval of a drug to treat lymphoma in dogs has been granted by the U.S. Food and Drug Administration. "While canine lymphoma affects fewer than 70,000 dogs in the U.S. annually, it ...

Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system.

The FDA has approved Laverdia, a drug to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia is an oral treatment and only available by prescription from a ...

CHAMPAIGN, Ill. — Researchers have identified a new target for the treatment of lymphoma and are testing a potential new drug in pet dogs afflicted with the disease. At low doses, the compound, called ...

The Food and Drug Administration (FDA) announced full approval for lymphoma treatment in dogs on Thursday, aiming to benefit quality of life and allow pets and their owners more time together. The ...

Researchers at North Carolina State University are narrowing the search for genes involved in non-Hodgkin lymphoma – by turning dogs into humans. Humans and dogs don't just share companionship and ...